Stock Alert
Prev Next
As on Sep 24, 2018 12:00 AM Your results on : Stock Alert    
Tata Steel in focus after inking deal to buy steel business of Usha Martin
24-Sep-2018 (08:23)

Tata Steel announced that it has executed definitive agreements for acquisition of the steel business of Usha Martin (UML) through a slump sale on a going concern basis. The closing of the acquisition is subject to fulfilment of various conditions under the agreements. At the closing, Tata Steel or any of its subsidiaries or affiliates may carry out this acquisition. The parties shall jointly work towards fulfilment of conditions precedent which are largely regulatory approvals required for the transfer of the business undertaking. All the employees pertaining to the steel business will transfer as part of the acquisition.

The steel business undertaking of UML inter-alia comprises of a specialized ~1.0 mtpa alloy based manufacturing capacity in long products segment based in Jamshedpur, a producing iron-ore mine, a coal mine under development and captive power plants. The acquisition is part of the overall strategy to build capability in long products and expand product offerings including high-value added products. The announcement was made on Saturday, 22 September 2018.

Biocon announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Fulphila, a biosimilar to Amgen's Neulasta (pegfilgrastim). The CHMP positive opinion will now be considered by the European Commission. The decision on approval is expected by November 2018. Fulphila was approved by the US Food and Drug Administration (FDA) earlier this year and is the first FDA-approved biosimilar for Neulasta in the US Regulatory applications for Fulphila also have been submitted in Australia, New Zealand, Canada and several other countries. The announcement was made made after market hours on Friday, 21 September 2018.

In a separate announcement, Biocon announced that the US Food and Drug Administration (USFDA) conducted a periodic Current Good Manufacturing Practice (cGMP) inspection of the company's drug substance manufacturing site at Bangalore Campus from 17 - 21 September 2018. The weeklong audit concluded without any observations and no Form 483 was issued. The successful audit of this site reflects our strong commitment to cGMP compliance. The announcement was made on Saturday, 22 September 2018.

Reliance Industries said its telecom unit, Reliance Jio Infocomm, announced a 5-year partnership with India's leading broadcaster, Star India to unleash a new era in sports entertainment. Jio and Star will make all televised India-cricket matches available to users of JioTV and Hotstar in India. Reliance Industries signed an agreement in this regard with Star India. This partnership will cover T20, One Day Internationals (ODI), International Test Cricket, Premier Domestic Competitions of the BCCI. The announcement was made made after market hours on Friday, 21 September 2018.

ITD Cementation India has received LOA/LOI aggregating Rs 845 crore for upgrading of passenger terminal building and Airside facilities at Tiruchirapalli (Trichy) International Airport by Airports Authority of India. Development of Refit Jetty and Allied facilities at Port Blair by The Ministry of Shipping, Government of India for Andaman Lakshadweep Harbour Works. The announcement was made made after market hours on Friday, 21 September 2018.

NBCC (India) in spotlight after securing new orders
21-Sep-2018 (08:14)
RITES may rise on bagging additional contract from Indian Railways
19-Sep-2018 (08:19)
Aurionpro Solutions in focus after Bank of Khartoum Group implements iCashpro+
18-Sep-2018 (08:23)
Infosys in focus on signing deal to buy Fluido
17-Sep-2018 (08:25)
Cipla in spotlight after South African regulator's approval for HIV drug
12-Sep-2018 (08:16)
Sun Pharma in focus on buying stake in Israeli startup Tarsius
11-Sep-2018 (08:17)
Tata Motors in focus after announcing JLR sales figures
10-Sep-2018 (08:45)
Bajaj Auto in focus on plan to expand 3-wheeler, quadricycle capacity
07-Sep-2018 (08:15)
Sagar Cements in spotlight after good cement sales
06-Sep-2018 (08:14)
Mcnally Bharat may rise after order win
05-Sep-2018 (08:08)
Persistent Systems in focus after acquisition
04-Sep-2018 (08:03)
Wipro in spotlight after bagging deal from Alight Solutions
03-Sep-2018 (08:14)
Dilip Buildcon may gain after new order win
31-Aug-2018 (08:44)
Reliance Infra in spotlight after completing sale
30-Aug-2018 (08:54)
SBI in focus on plans to sell stake in NSE
29-Aug-2018 (08:48)
Jet Airways (India) may drop after dismal Q1 result
28-Aug-2018 (08:55)
RIL in focus after stake hike in Genesis Colors
27-Aug-2018 (08:56)
Britannia Industries in spotlight after board OKs stock split
24-Aug-2018 (08:17)
Lupin in focus after USFDA approval for generic
23-Aug-2018 (08:11)
Connect with us :   
About us
Our Services
Core Values
Investor Relations
Product & Services
Institutional Broking
Clearing Services
Trade & Products
Globe Connect Pro
Globe Trade Smart
Globe Connect Mobile/Tablet
Globe News Connect
Globe e-KYC Application
Back Office
Back Office
KYC/KDC Status
Mutual Fund
RMS Policy
Download Forms
Useful Links
Exchange Holidays
Anti-Money Laundering Policy
Policies, Procedures, Rights, Obligations and RDD

Funds Payout Policy
Guidance Note on FATCA and CRS May 2016
Right and Obligation, RDD, Guidance Note in Vernacular Language - Equity | Commodity
Additional Risk Disclosure for Trading into Commodity options
In case of any grievances pleae write to / (For Trading) (For DP) (For PMS) (For Commodities)
Equity SEBI Registration No INZ000177137. Exchange Registration Nos NSE : TM No. - 06637, Clearing No.- M50302 | BSE : Clearing No.- 3179 | MSEI : TM Code-1004, Clearing Member Code- 4 | SEBI Registration for DP : IN-DP-NSDL-97-99, NSDL- DP ID: IN300966, CDSL DP ID: 12020600 | SEBI Research Analysts Registration No. INH100001187 | SEBI PMS Registration No. INP00000236
* Through subsidiary Globe Commodities Ltd. --> Commodity SEBI Regn. No. - INZ000024939, Exchange Regn. Nos. - MCX CM ID: 8550 TM ID: 10735, NCDEX CM ID: M50011 TM ID: 00012, NMCE ID: CL0111, ICEX ID: 1009, NCDXSPOT-CR-07-10011,
** Through step in subsidiary Globe Comex International DMCC --> DGCX **TM Id.1064, CM Id.3064*
"We also do Pro-Account trading in Commodity Segment.."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Attention Investors:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your Stock Brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors"
"Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day......................issued in the interest of investors."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
© 2013 Globe Capital Market Limited. All rights reserved
Designed, Developed and Content powered by C-MOTS Infotech (ISO 9001:2015 Certified) Privacy Policy Disclaimer Terms and Conditions